Home/Ona Therapeutics/Antoine J. Yver
AJ

Antoine J. Yver

Independent Chair of the Board

Ona Therapeutics

Therapeutic Areas

Ona Therapeutics Pipeline

DrugIndicationPhase
ONA-255Refractory Breast Cancer and Solid TumorsPre-clinical
ONA-389Prevalent Solid TumorsPre-clinical